WATERTOWN, Mass. — September 3, 2025 — Leads & Copy — Kymera Therapeutics, Inc. (NASDAQ: KYMR) has appointed Brian Adams, JD, as Chief Legal Officer and Corporate Secretary. Mr. Adams, a legal executive with experience in the life sciences, will lead Kymera’s legal, governance, and intellectual property functions. He succeeds Ellen Chiniara, who is retiring.
Nello Mainolfi, PhD, Founder, President and CEO of Kymera Therapeutics, said that Mr. Adams’ leadership and expertise will be instrumental as the company advances its programs through clinical development and toward commercialization. Mr. Adams said he was drawn to Kymera by its commitment to scientific innovation and clinical impact.
Before joining Kymera, Mr. Adams was Chief Legal Officer of Relay Therapeutics. He also served as Senior Vice President, General Counsel and Secretary at Keryx Biopharmaceuticals. Mr. Adams holds a B.A. from Harvard University and a J.D. from the Catholic University of America’s Columbus School of Law.
Kymera Therapeutics is a clinical-stage biotechnology company focused on targeted protein degradation (TPD) to develop medicines.
Contact: Justine Koenigsberg, Vice President, Investor Relations, investors@kymeratx.com, media@kymeratx.com, 857-285-5300
Source: Kymera Therapeutics, Inc.
